BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 27431938)

  • 1. The transporter and permeability interactions of asymmetric dimethylarginine (ADMA) and L-arginine with the human blood-brain barrier in vitro.
    Watson CP; Pazarentzos E; Fidanboylu M; Padilla B; Brown R; Thomas SA
    Brain Res; 2016 Oct; 1648(Pt A):232-242. PubMed ID: 27431938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the cardiovascular risk marker asymmetric dimethylarginine (ADMA) with the human cationic amino acid transporter 1 (CAT1).
    Strobel J; Mieth M; Endress B; Auge D; König J; Fromm MF; Maas R
    J Mol Cell Cardiol; 2012 Sep; 53(3):392-400. PubMed ID: 22705145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss.
    Milewski K; Bogacińska-Karaś M; Fręśko I; Hilgier W; Jaźwiec R; Albrecht J; Zielińska M
    Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099056
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cationic amino acid transport across the blood-brain barrier is mediated exclusively by system y+.
    O'Kane RL; Viña JR; Simpson I; Zaragozá R; Mokashi A; Hawkins RA
    Am J Physiol Endocrinol Metab; 2006 Aug; 291(2):E412-9. PubMed ID: 16569760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetric dimethylarginine impairs glucose utilization via ROS/TLR4 pathway in adipocytes: an effect prevented by vitamin E.
    Yang ZC; Wang KS; Wu Y; Zou XQ; Xiang YY; Chen XP; Li YJ
    Cell Physiol Biochem; 2009; 24(1-2):115-24. PubMed ID: 19590199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of simvastatin on CAT-1-mediated arginine transport and NO level under high glucose conditions in conditionally immortalized rat inner blood-retinal barrier cell lines (TR-iBRB).
    Tun T; Kang YS
    Microvasc Res; 2017 May; 111():60-66. PubMed ID: 28089735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-arginine regulates asymmetric dimethylarginine metabolism by inhibiting dimethylarginine dimethylaminohydrolase activity in hepatic (HepG2) cells.
    Wang J; Sim AS; Wang XL; Wilcken DE
    Cell Mol Life Sci; 2006 Dec; 63(23):2838-46. PubMed ID: 17075694
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Asymmetric dimethylarginine regulates the lipopolysaccharide-induced nitric oxide production in macrophages by suppressing the activation of NF-kappaB and iNOS expression.
    Pekarova M; Kubala L; Martiskova H; Bino L; Twarogova M; Klinke A; Rudolph TK; Kuchtova Z; Kolarova H; Ambrozova G; Kuchta R; Kadlec J; Lojek A
    Eur J Pharmacol; 2013 Aug; 713(1-3):68-77. PubMed ID: 23665490
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells.
    Davids M; Teerlink T
    Metabolism; 2013 Oct; 62(10):1455-61. PubMed ID: 23890667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Age-related changes in ADMA-DDAH-NO pathway in rat liver subjected to partial ischemia followed by global reperfusion.
    Trocha M; Merwid-Ląd A; Chlebda-Sieragowska E; Szuba A; Pieśniewska M; Fereniec-Gołębiewska L; Kwiatkowska J; Szeląg A; Sozański T
    Exp Gerontol; 2014 Feb; 50():45-51. PubMed ID: 24269305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Asymmetric dimethylarginine induces oxidative and nitrosative stress in murine lung epithelial cells.
    Wells SM; Holian A
    Am J Respir Cell Mol Biol; 2007 May; 36(5):520-8. PubMed ID: 17158357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Developmental changes of l-arginine transport at the blood-brain barrier in rats.
    Tachikawa M; Hirose S; Akanuma SI; Matsuyama R; Hosoya KI
    Microvasc Res; 2018 May; 117():16-21. PubMed ID: 29247719
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency.
    Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R
    Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated regulation of dimethylarginine dimethylaminohydrolase-1 and cationic amino acid transporter-1 by farnesoid X receptor in mouse liver and kidney and its implication in the control of blood levels of asymmetric dimethylarginine.
    Li J; Wilson A; Gao X; Kuruba R; Liu Y; Poloyac S; Pitt B; Xie W; Li S
    J Pharmacol Exp Ther; 2009 Oct; 331(1):234-43. PubMed ID: 19605523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of asymmetric dimethylarginine and arginine in the failing heart and its vasculature.
    Visser M; Paulus WJ; Vermeulen MA; Richir MC; Davids M; Wisselink W; de Mol BA; van Leeuwen PA
    Eur J Heart Fail; 2010 Dec; 12(12):1274-81. PubMed ID: 20923854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adverse effects of cigarette smoke on NO bioavailability: role of arginine metabolism and oxidative stress.
    Zhang WZ; Venardos K; Chin-Dusting J; Kaye DM
    Hypertension; 2006 Aug; 48(2):278-85. PubMed ID: 16801489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells.
    Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ
    Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DDAH-1, via regulation of ADMA levels, protects against ischemia-induced blood-brain barrier leakage.
    Zhao Y; Ma X; Zhou Y; Xie J; Liu X; Zhao Y
    Lab Invest; 2021 Jul; 101(7):808-823. PubMed ID: 33574439
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transport of asymmetric dimethylarginine (ADMA) by cationic amino acid transporter 2 (CAT2), organic cation transporter 2 (OCT2) and multidrug and toxin extrusion protein 1 (MATE1).
    Strobel J; Müller F; Zolk O; Endreß B; König J; Fromm MF; Maas R
    Amino Acids; 2013 Oct; 45(4):989-1002. PubMed ID: 23864433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.